BFM
JSPRW icon

Boothbay Fund Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Boothbay Fund Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$313K Hold
357,447
– – ﹤0.01% 1589
2025
Q4 		$654K Hold
357,447
– – 0.01% 998
2025
Q3 		$851K Buy
+357,447
New +$30.4K 0.01% 902
2021
Q1 		– Sell
-24,622
Closed -$246K – 1659
2020
Q4 		$246K Hold
24,622
– – 0.01% 1024
2020
Q3 		$244K Sell
24,622
-5,678
-19% -$5.74K 0.01% 872
2020
Q2 		$311K Buy
+30,300
New +$18.9K 0.02% 690

Other funds holding JSPRW

Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boothbay Fund Management's JSPRW Position: Q1 2026 in Review

Boothbay Fund Management held its Japer Therapeutics Warrants (JSPRW) position steady in Q1 2026 at 357,447 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1589.

Boothbay Fund Management first reported a position in JSPRW in Q2 2020 and has held it in 6 quarters since. The position peaked at $851K in Q3 2025. 7 funds tracked by Wall St. Rank hold JSPRW as of Q1 2026.

  • Boothbay Fund Management held 357,447 shares of Japer Therapeutics Warrants worth $313K as of Q1 2026.
  • Boothbay Fund Management left its Japer Therapeutics Warrants share count unchanged in Q1 2026.
  • Japer Therapeutics Warrants made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1589 holding.
  • Boothbay Fund Management first reported a position in Japer Therapeutics Warrants in Q2 2020 and has held it in 6 quarters since.
  • Boothbay Fund Management's Japer Therapeutics Warrants position peaked at $851K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.